September 30, 2025 a 01:00 pm
LLY: Fundamental Ratio Analysis - Eli Lilly and Company
Eli Lilly and Company, a leader in the global pharmaceutical industry, continues to showcase strong fundamentals driven by its extensive product lineup and strategic partnerships. Despite challenges in the drug manufacturing sector, the company's focus on innovation and strategic growth has resulted in solid market performance. However, potential investors should consider the inherent risks associated with market fluctuations and sector volatility.
Fundamental Rating
The fundamental rating provides insight into Eli Lilly's financial health and market performance. Scores highlight strengths in return metrics despite challenges in valuation multiples.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return on Equity (ROE) | 5 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings (P/E) | 1 | |
| Price to Book (P/B) | 1 |
Historical Rating
The historical scores reflect Eli Lilly's stable and consistent performance metrics, maintaining strong returns over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-29 | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
| Historical Average | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
Analyst Price Targets
Analyst price targets suggest strong bullish sentiment with notable upside potential within the forecasted range.
| High | Low | Median | Consensus |
|---|---|---|---|
| 1050 | 700 | 770 | 803.33 |
Analyst Sentiment
The analyst sentiment remains positive, with a majority recommending a buy, reflecting confidence in Eli Lilly's market potential.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 31 | |
| Hold | 9 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
Eli Lilly and Company presents a robust investment opportunity, backed by strong fundamentals and a diverse product portfolio. The consistent performance and strategic partnerships bode well for future growth. However, investors should be cautious of sector-specific risks and market volatility. Overall, the stock's performance and analyst sentiment suggest a promising outlook with potential for appreciation. Keep a close watch on market trends and company news for timely decision-making.